These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7973226)

  • 21. On the timing of a futility analysis in clinical trials.
    Pallay A
    J Biopharm Stat; 2000 Aug; 10(3):399-405. PubMed ID: 10959919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early stopping of prevention trials when multiple outcomes are of interest: a discussion.
    Green SB; Freedman LS
    Stat Med; 1994 Jul 15-30; 13(13-14):1479-84. PubMed ID: 7973227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AIDS, ethics, and clinical trials. Institute of Medical Ethics Working Party on the Ethical Implications of AIDS.
    BMJ; 1992 Sep; 305(6855):699-701. PubMed ID: 1393120
    [No Abstract]   [Full Text] [Related]  

  • 24. Evidence based medicine and ethics.
    Hope T
    J Med Ethics; 1995 Oct; 21(5):259-60. PubMed ID: 8558537
    [No Abstract]   [Full Text] [Related]  

  • 25. The ethics of randomised controlled trials: a matter of statistical belief?
    Hutton JL
    Health Care Anal; 1996 May; 4(2):95-102. PubMed ID: 10162773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Interpretation of clinical studies].
    Jahrmäker H
    Med Klin (Munich); 1995 Jan; 90(1):45-52. PubMed ID: 7885305
    [No Abstract]   [Full Text] [Related]  

  • 27. Some practical aspects of the interim monitoring of clinical trials.
    Simon R
    Stat Med; 1994 Jul 15-30; 13(13-14):1401-9. PubMed ID: 7973219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of therapeutic research on informed consent and the ethics of clinical trials: a medical oncology perspective.
    Daugherty CK
    J Clin Oncol; 1999 May; 17(5):1601-17. PubMed ID: 10334550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early stopping of clinical trials in lupus and other uncommon rheumatologic diseases.
    LaValley MP; Felson DT
    Lupus; 1999; 8(8):698-703. PubMed ID: 10568909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unbelievable Folly of Clinical Trials in Heart Failure: The Inconvenient Truth About How Investigators and Guidelines Weigh Evidence.
    Packer M
    Circ Heart Fail; 2016 Apr; 9(4):e002837. PubMed ID: 27009552
    [No Abstract]   [Full Text] [Related]  

  • 31. Research ethics and clinical trials: fostering collaboration with research participants.
    Phipps E; Fleetwood J; Piraino A
    Account Res; 1999; 6(3):215-26. PubMed ID: 11658125
    [No Abstract]   [Full Text] [Related]  

  • 32. Applying Bayesian ideas in drug development and clinical trials.
    Spiegelhalter DJ; Freedman LS; Parmar MK
    Stat Med; 1993 Aug; 12(15-16):1501-11; discussion 1513-7. PubMed ID: 8248659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What is sufficient evidence for the reliability and validity of patient-reported outcome measures?
    Frost MH; Reeve BB; Liepa AM; Stauffer JW; Hays RD;
    Value Health; 2007; 10 Suppl 2():S94-S105. PubMed ID: 17995479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analyzing and Interpreting Clinical Trials.
    Spino C
    Gastroenterology; 2016 Apr; 150(4):797-800. PubMed ID: 26924090
    [No Abstract]   [Full Text] [Related]  

  • 35. Enhancing the understanding of clinically meaningful results: A clinical research perspective.
    Nordahl-Hansen A; Øien RA; Volkmar F; Shic F; Cicchetti DV
    Psychiatry Res; 2018 Dec; 270():801-806. PubMed ID: 30551328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ethics of clinical trials from bayesian perspective: society's role is important.
    Senn SJ
    BMJ; 2003 Jun; 326(7404):1456-7. PubMed ID: 12829564
    [No Abstract]   [Full Text] [Related]  

  • 37. Problems in controlled trials--a critical response.
    Vere DW
    J Med Ethics; 1983 Jun; 9(2):85-9. PubMed ID: 6876103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Informed consent: ethical, legal, and medical implications for doctors and patients who participate in randomised clinical trials.
    Br Med J (Clin Res Ed); 1983 Apr; 286(6371):1117-21. PubMed ID: 6404349
    [No Abstract]   [Full Text] [Related]  

  • 39. [What does "power of the study" mean? How to compute the power of a study? How to compute the number of subjects needed for a trial?].
    Mélot C
    Rev Mal Respir; 2003 Sep; 20(4):602-3. PubMed ID: 14528163
    [No Abstract]   [Full Text] [Related]  

  • 40. Outcome reporting bias in clinical trials.
    Esposito E; Cipriani A; Barbui C
    Epidemiol Psichiatr Soc; 2009; 18(1):17-8. PubMed ID: 19378694
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.